BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8472497)

  • 1. Acute promyelocytic leukaemia following radioiodine therapy.
    Richards EM; Marcus RE
    Clin Lab Haematol; 1993; 15(1):55-8. PubMed ID: 8472497
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute leukemias after treatment with radioiodine for thyroid cancer.
    Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
    Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
    Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
    J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 5. The beginnings of radioiodine therapy of metastatic thyroid carcinoma: a memoir of Samuel M. Seidlin, M. D. (1895-1955) and his celebrated patient.
    Siegel E
    Cancer Biother Radiopharm; 1999 Apr; 14(2):71-9. PubMed ID: 10850290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia in a young patient with breast cancer.
    Kara O; Ozdemir E; Arslan C; Dogan E; Altundag K
    Med Oncol; 2011 Mar; 28(1):249-50. PubMed ID: 20140540
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid.
    Bundi RS; Scott JS; Halnan KE
    Br J Radiol; 1977 Jan; 50(589):61-4. PubMed ID: 264404
    [No Abstract]   [Full Text] [Related]  

  • 8. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
    Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
    J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
    de Vathaire F
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature.
    Wiernik PH; Muse IM
    Leukemia; 1996 Jan; 10(1):178-82. PubMed ID: 8558926
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.
    Laurenti L; Salutari P; Sica S; Piccirillo N; Zini G; Zollino M; Leone G
    Ann Hematol; 1998 Jun; 76(6):271-2. PubMed ID: 9692815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
    Wang KL; Lin LY; Chen PM; Lin HD
    J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weighing shadows: can meta-analysis help define the risk-benefit ratio of RAI treatment for low-risk thyroid cancer patients?
    Schneider AB; Viana MA; Ron E
    Thyroid; 2009 May; 19(5):435-6. PubMed ID: 19415992
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemia developing after 131I treatment for thyroid cancer in a patient with Werner's syndrome: molecular and cytogenetic studies.
    Takemoto Y; Hata T; Kamino K; Mitsuda N; Miki T; Kawagoe H; Ogihara T
    Intern Med; 1995 Sep; 34(9):863-7. PubMed ID: 8580557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia after 131I treatment of thyroid cancer--comments on the article 'Second cancer following chemotherapy and radiotherapy--an epidemiological perspective' by J. Kaldor.
    Advani SH; Hege UP
    Acta Oncol; 1992; 31(1):65. PubMed ID: 1586507
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
    Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Report of a case and review of the literature.
    Walgraeve D; Verhoef G; Stul M; Cassiman JJ; Mecucci C; Van den Berghe H; Boogaerts M
    Cancer Genet Cytogenet; 1991 Sep; 55(2):217-24. PubMed ID: 1933823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Four cases of hematologic malignancy following radioactive iodine therapy for thyroid cancer].
    Im M; Lee JK; Hong YJ; Hong SI; Kang HJ; Na II; Ryoo BY; Cheon GJ; Lee HN; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):425-9. PubMed ID: 19127106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
    Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
    Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of therapy-related extramedullary acute promyelocytic leukemia.
    Chen Z; Mostafavi HS; Shevrin DH; Morgan R; Vye MV; Stone JF; Sandberg AA
    Cancer Genet Cytogenet; 1996 Jan; 86(1):29-30. PubMed ID: 8616781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.